Results 81 to 90 of about 1,054,709 (177)
Genomic landscape of pediatric adrenocortical tumors
Pediatric adrenocortical carcinoma is a rare malignancy with poor prognosis. Here we analyze 37 adrenocortical tumors (ACTs) by whole genome, whole exome and/or transcriptome sequencing.
Mardis, Elaine R. +23 more
core +1 more source
Rare childhood tumors in a Turkish pediatric oncology center
Background: It has been estimated that rare tumor rate is about 15% of all childhood cancer in United States. According to Turkish Pediatric Oncology Group (TPOG) datas, 8889 children were diagnosed between 2002 and 2008 in our country and 3.7% of them ...
Nurdan Tacyildiz +9 more
doaj +1 more source
Regarding the Children's Oncology Group ARAR0332 Protocol for Pediatric Adrenocortical Carcinoma [PDF]
Ji-Gan Wang, Dun-Chang Mo
openaire +2 more sources
A Pediatric Case of Adrenocortical Carcinoma [PDF]
Adrenocortical carcinoma is a rare malignant disease with a poor prognosis that occurs at a rate of 0.3 per 1 million children per year. Since the development of adrenocortical carcinoma in children commonly involves hormonal functional tumors, it is ...
安達, 裕行 +11 more
core +1 more source
With recent progress in understanding the pathogenesis of adrenocortical tumors (ACTs), identification of molecular markers to predict their prognosis has become possible.
Barbara dos Santos Passaia +6 more
doaj +1 more source
Non functional adrenocortical carcinoma [PDF]
Adrenocortical carcinoma is a rare disease with an incidence of approximately 1-2 per million populations per year. The main symptoms are abdominal mass with or without endocrine dysfunction. However, there are difficulties in the diagnosis and treatment
Nataprawira, Memet, Nugroho, Adianto
core +1 more source
Pediatric Adrenocortical Carcinoma: Diagnostic Challenges and Therapeutic Approach — A Case Report
Adrenocortical carcinoma (ACC) is a rare tumor. It constitutes 0.2% of malignant tumors in children and it is considered ten times rarer than in adults. Patients with predisposing syndromes like Li-Fraumeni or Beckwith-Wiedemann may develop these tumors. Clinical symptoms are dominated by endocrine signs, which are present in 90% of cases. The primary
Assia Haif, Djelloul Achouri
openaire +1 more source
Adrenocortical carcinoma is a rare and aggressive malignancy with varying presentations. Histologic criteria for distinguishing malignancy from benignity are challenging and make it difficult to assign a clear prognosis.
Richard B. Mertens +5 more
core +1 more source
Ahmed Adam Osman,1 Ahmed Omar Abdi,2 Ismail Mohamud Abdullahi,3 Mehmet Tahtabasi,4 Veysel Kaya5 1Department of Radiology, University of Health Sciences-Somalia Turkey Recep Tayyip Erdogan Education and Research Hospital, Mogadishu, Somalia; 2Department ...
Osman AA +4 more
doaj
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source

